| scholarly article | Q13442814 |
| P2093 | author name string | C Erik Hack | |
| Sacha Zeerleder | |||
| Walter A Wuillemin | |||
| Irmela Sulzer | |||
| Christoph Caliezi | |||
| Gerard van Mierlo | |||
| Anke Eerenberg-Belmer | |||
| P2860 | cites work | Released granulocytic elastase: an indicator of pathobiochemical alterations in septicemia after abdominal surgery | Q68946428 |
| Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects | Q69191536 | ||
| Specific degranulation of human polymorphonuclear leukocytes | Q69746944 | ||
| Sensitive ELISA for interleukin-6. Detection of IL-6 in biological fluids: synovial fluids and sera | Q70141839 | ||
| Interleukin 8-related neutrophil elastase and the severity of the adult respiratory distress syndrome | Q70948265 | ||
| Activation of human neutrophils by C3a and C5A. Comparison of the effects on shape changes, chemotaxis, secretion, and respiratory burst | Q72020363 | ||
| Application of a monoclonal antibody against a neoepitope on activated C4 in an ELISA for the quantification of complement activation via the classical pathway | Q72088344 | ||
| Plasma elastase levels and the development of the adult respiratory distress syndrome | Q72205010 | ||
| Neutrophil-mediated damage to vascular endothelium in the spontaneously hypertensive rat | Q73398965 | ||
| Increased Neutrophil Elastase, Persistent Intravascular Coagulation, and Decreased Fibrinolytic Activity in Patients with Posttraumatic Acute Respiratory Distress Syndrome | Q73483298 | ||
| C1 esterase inhibitor concentrate for capillary leakage syndrome following bone marrow transplantation | Q73877807 | ||
| Effect of C1 inhibitor on inflammatory and physiologic response patterns in primates suffering from lethal septic shock | Q74463712 | ||
| Blood concentrations of polymorphonuclear leucocyte elastase and interleukin-6 are indicators for the occurrence of multiple organ failures at the early stage of acute pancreatitis | Q77904781 | ||
| Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine | Q22306067 | ||
| Proteolytic cleavage and inactivation of alpha 2-plasmin inhibitor and C1 inactivator by human polymorphonuclear leukocyte elastase | Q24302265 | ||
| Neutrophil-mediated injury to endothelial cells. Enhancement by endotoxin and essential role of neutrophil elastase | Q28361648 | ||
| The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine | Q29618869 | ||
| Interleukin 12 induces activation of fibrinolysis and coagulation in humans | Q33181606 | ||
| Plakalbumin, alpha 1-antitrypsin, antithrombin and the mechanism of inflammatory thrombosis | Q33366060 | ||
| Lactoferrin: a multifunctional glycoprotein involved in the modulation of the inflammatory process | Q33649849 | ||
| Complement activation in relation to capillary leakage in children with septic shock and purpura | Q33767719 | ||
| C1-Esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema. | Q33852899 | ||
| The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study | Q34314569 | ||
| Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils | Q35815126 | ||
| Neutrophil-mediated damage to human vascular endothelium. Role of cytokine activation | Q35832547 | ||
| A pilot study to evaluate the effects of C1 esterase inhibitor on the toxicity of high-dose interleukin 2. | Q35978327 | ||
| Sequential degranulation of the two types of polymorphonuclear leukocyte granules during phagocytosis of microorganisms | Q36195414 | ||
| Mechanisms of lysosomal enzyme release from human polymorphonuclear leukocytes. Effects of phorbol myristate acetate | Q36197048 | ||
| Purified human plasma kallikrein aggregates human blood neutrophils | Q36983589 | ||
| Human plasma kallikrein releases neutrophil elastase during blood coagulation | Q36992361 | ||
| Tissue destruction by neutrophils | Q38264463 | ||
| Intravenous infusion of erythromycin inhibits CXC chemokine production, but augments neutrophil degranulation in whole blood stimulated with Streptococcus pneumoniae | Q39439974 | ||
| Prediction of microbial infection and mortality in medical patients with fever: plasma procalcitonin, neutrophilic elastase-alpha1-antitrypsin, and lactoferrin compared with clinical variables | Q40633286 | ||
| Demonstration of granulocytic proteases in plasma of patients with acute leukemia and septicemia with coagulation defects | Q40640549 | ||
| Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock | Q40865699 | ||
| Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation | Q40948608 | ||
| Role of cytokines in sepsis. | Q41610123 | ||
| Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production | Q42942780 | ||
| Complement activation and polymorphonuclear neutrophil leukocyte elastase in sepsis. Correlation with severity of disease. | Q43464081 | ||
| C1-inhibitor in patients with severe sepsis and septic shock: beneficial effect on renal dysfunction | Q44090857 | ||
| Relationship between neopterin and granulocyte elastase plasma levels and the severity of multiple organ failure | Q44463247 | ||
| Neutrophil elastase promotes lung microvascular injury and proteolysis of endothelial cadherins | Q47770039 | ||
| Specific complement inhibition with heparin-coated extracorporeal circuits. | Q51575251 | ||
| The Logistic Organ Dysfunction system. A new way to assess organ dysfunction in the intensive care unit. ICU Scoring Group. | Q52199824 | ||
| Release of interleukin-12 in experimental Escherichia coli septic shock in baboons: relation to plasma levels of interleukin-10 and interferon-gamma. | Q54586932 | ||
| Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. | Q54704880 | ||
| C1-inhibitor concentrate for sepsis-related capillary leak syndrome | Q67515579 | ||
| Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis | Q67755145 | ||
| A modified competitive inhibition radioimmunoassay for the detection of C3a. Use of 125I-C3 instead of 125I-C3a | Q68092050 | ||
| Participation and interactions of neutrophil elastase in haemostatic disorders of patients with severe infections | Q68161450 | ||
| Neutrophil activation in acute renal failure and sepsis | Q68765676 | ||
| Purified plasma factor XIIa aggregates human neutrophils and causes degranulation | Q68798232 | ||
| P433 | issue | 4 | |
| P921 | main subject | sepsis | Q183134 |
| P304 | page(s) | 529-535 | |
| P577 | publication date | 2003-07-01 | |
| P1433 | published in | Clinical and Vaccine Immunology | Q5133811 |
| P1476 | title | Administration of C1 inhibitor reduces neutrophil activation in patients with sepsis | |
| P478 | volume | 10 |
| Q37336472 | Anti-inflammatory interventions-what has worked, not worked, and what may work in the future |
| Q28972362 | BIOLOGICAL ACTIVITIES OF C1 INHIBITOR |
| Q35567084 | Bench-to-bedside review: the role of C1-esterase inhibitor in sepsis and other critical illnesses |
| Q35567004 | Blood transfusion during cardiac surgery is associated with inflammation and coagulation in the lung: a case control study. |
| Q37273299 | Harmful molecular mechanisms in sepsis |
| Q47126929 | Immunohaemostasis: a new view on haemostasis during sepsis |
| Q35758663 | Increased Nucleosomes and Neutrophil Activation Link to Disease Progression in Patients with Scrub Typhus but Not Murine Typhus in Laos |
| Q58699858 | Induction of the pneumococcal vncRS operon by lactoferrin is essential for pneumonia |
| Q50978969 | Interleukin-6, -7, -8 and -10 predict outcome in acute myocardial infarction complicated by cardiogenic shock. |
| Q92914442 | Mechanisms of haemolysis-induced kidney injury |
| Q41821623 | Nebulized C1-Esterase Inhibitor does not Reduce Pulmonary Complement Activation in Rats with Severe Streptococcus Pneumoniae Pneumonia. |
| Q36175438 | Neutrophil elastase activity in pulmonary venous blood during lung resection |
| Q36369202 | Neutrophil extracellular traps in the host defense against sepsis induced by Burkholderia pseudomallei (melioidosis) |
| Q55366266 | No association between systemic complement activation and intensive care unit-acquired weakness. |
| Q45764716 | Pharmacokinetic–pharmacodynamic analysis of human purified C1-esterase inhibitor in patients with sepsis |
| Q34720987 | Successful use of daily intravenous infusion of C1 esterase inhibitor concentrate in the treatment of a hereditary angioedema patient with ascites, hypovolemic shock, sepsis, renal and respiratory failure |
| Q64093787 | Systemic inflammation induces release of cell-free DNA from hematopoietic and parenchymal cells in mice and humans |
| Q38783936 | The effect of C1-esterase inhibitor on systemic inflammation in trauma patients with a femur fracture - The CAESAR study: study protocol for a randomized controlled trial |
| Q27027974 | The role of complement system in septic shock |
| Q38104081 | Transfusion-related acute lung injury: a clinical review |
Search more.